PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Study backs RSV vaccine safety during pregnancy

2024-07-08
(Press-News.org) Vaccinating mothers against respiratory syncytial virus (RSV) during late pregnancy to protect their newborns is not associated with an increased risk of preterm birth or other poor outcomes, according to a study by Weill Cornell Medicine and NewYork-Presbyterian investigators. Infants are particularly vulnerable to the virus which can cause a serious lower respiratory illness.

The study published in JAMA Network Open on July 8 adds real-world evidence to the existing data from clinical trials about the safety of Pfizer’s Abrysvo vaccine. The researchers found that there wasn’t a significant statistical difference in preterm birth rates between vaccinated women (5.9 percent) and unvaccinated women (6.7 percent). 

“The real-world evidence provides an additional layer of confidence about the safety of this vaccine during pregnancy,” said the study’s lead author Dr. Moeun Son, associate professor of obstetrics and gynecology at Weill Cornell Medicine. “Randomized clinical trials don’t always emulate the populations we see in the clinical setting, but now we have data from multiple populations showing no increase in preterm birth risk.”

The study’s senior author is Dr. Heather Lipkind, professor of obstetrics and gynecology and director of Clinical Maternal-Fetal Medicine at Weill Cornell Medicine and a gynecologist-obstetrician at NewYork-Presbyterian/Weill Cornell Medical Center.

RSV Protection from Day One Every year, RSV infections cause up to 80,000 hospitalizations and up to 300 deaths in children under five, according to the U.S. Centers for Disease Control and Prevention (CDC). For the first time last fall, mothers could reduce this risk— in August 2023, the U.S. Food and Drug Administration approved the Abrysvo vaccine for women between 32 and 36 weeks of pregnancy based on clinical trial results.

A month later, the CDC’s Advisory Committee on Immunization Practices recommended the vaccine for eligible pregnant women during RSV season, September to the end of January. The single-dose shot stimulates production of protective antibodies that are transferred from mother to infant through the placenta.  

To further study the vaccine’s safety in actual practice, Dr. Son and her colleagues analyzed pregnancy outcomes in 1,026 vaccinated and 1,947 unvaccinated patients who received care at NewYork-Presbyterian/Weill Cornell Medical Center and NewYork-Presbyterian Lower Manhattan Hospital during the first year the vaccinations were available. All patient data was de-identified to protect privacy.

In addition to preterm birth rate, the team evaluated other birth risks in vaccinated and unvaccinated pregnant women. The two groups had similar rates of stillbirths, small-for-gestational-age birthweight, neonatal intensive care unit (NICU) admissions, respiratory distress with NICU admissions, jaundice, low blood sugar and sepsis among the newborns.

The data are particularly reassuring because they include some women with health conditions that could increase the risks of poor pregnancy outcomes who were excluded from the vaccine clinical trial. “Patients and clinicians can feel confident that vaccination during pregnancy is a safe way to protect infants from harmful RSV infections,” said Dr. Son, who is also a maternal-fetal medicine physician at NewYork-Presbyterian/Weill Cornell Medical Center.

Vaccination Rates Can be Improved To verify their results, Dr. Son and her colleagues conducted three separate analyses using different statistical methods. In one of the three analyses, they found a slightly increased risk of high blood pressure during pregnancy in vaccinated women. However, whether the difference in that analysis reflects a genuine concern or is the result of chance or differences between the two groups of women is still being determined. For example, vaccinated women were more likely to have insurance or to have undergone in vitro fertilization.

“These are things we will continue to explore in future studies,” Dr. Son said. 

The study also showed that the two New York City hospitals vaccinated 35 percent of the pregnant women under their care, which is almost double the national average of 18 percent. “We had onsite availability of the RSV vaccine in most of our prenatal outpatient clinics, which we think increased vaccination rates,” Dr. Son said.

However, the researchers identified some disparities in vaccination rates. Black women, women with public insurance and those who had fewer prenatal visits were less likely to be vaccinated. 

“As we prepare for the next RSV vaccination season in September, we are going to speak with different communities to help understand what might cause vaccine hesitancy among women or create barriers to access," Dr. Son said. "We want to ensure that all who would benefit will receive the vaccine.”

This study received support from New York-Presbyterian Hospital and the Clinical and Translational Science Center (UL1 TR002384) and the Joint Clinical Trials Office at Weill Cornell Medicine.

END


ELSE PRESS RELEASES FROM THIS DATE:

Brigham study finds new program streamlined hospice transitions from the emergency department

2024-07-08
KEY TAKEAWAYS After implementing a new hospice transition program, 210 out of 388 patients (54.1 percent) at Brigham and Women’s Hospital transitioned to hospice from the emergency department (ED) within 96 hours, compared to 61 of 270 patients (22.1 percent) in the control period. Across all groups, the presence of a Medical Order for Life-Sustaining Treatment plan (MOLST), was independently associated with hospice transition. These findings suggest that hospice transition programs can help improve use of hospice for patients presenting at the ED near the end ...

Diet quality among children

2024-07-08
About The Study: Although total dietary quality scores among U.S. children improved overall during 2005-2020, the increase remained suboptimal: lower than 5 points, a significant threshold for children in this analysis of changes in diet quality. Corresponding Author: To contact the corresponding author, Yongjun Zhang, Ph.D., M.D., email zhangyongjun@sjtu.edu.cn. To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/ (doi:10.1001/jamapediatrics.2024.1880) Editor’s Note: Please see the article for additional information, ...

Acceptability of hospital-at-home care and capacity for caregiver burden

2024-07-08
About The Study: Survey respondents reported substantial acceptability of hospital-at-home care, which did not vary across sociodemographics, health insurance coverage, health status, prior hospitalizations, or telehealth use. Approximately half of respondents agreed that hospital-at-home care was effective, safe, and convenient. Most indicated capacity to perform many caregiver tasks. Corresponding Author: To contact the corresponding author, Melissa A. Frasco, Ph.D., email mfrasco@usc.edu. To access the embargoed ...

Semaglutide vs tirzepatide for weight loss in adults with overweight or obesity

2024-07-08
About The Study: In this population of adults with overweight or obesity, use of tirzepatide was associated with significantly greater weight loss than semaglutide. Future study is needed to understand differences in other important outcomes.  Corresponding Author: To contact the corresponding author, Nicholas L. Stucky, M.D., email nicholass@truveta.com. To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/ (doi:10.1001/jamainternmed.2024.2525) Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest ...

AJPH study shows that permit to purchase laws are a promising avenue to reduce suicides in young adults

AJPH study shows that permit to purchase laws are a promising avenue to reduce suicides in young adults
2024-07-08
In 2020, suicide ranked as the third leading cause of death for adults aged 18 to 20 years in the United States.  Firearms were implicated in approximately half of these cases, and by 2017, they had surpassed motor vehicles as the leading cause of death in this age group. While ongoing debates on gun violence and mental health have increased public support for restricted firearm access, not much is known about the impact of gun control policies on young adults.   To fill this knowledge gap, a recent study published in the August issue of the American Journal of Public Health on July 03, ...

Companies that mitigate climate change reduce their cost of capital

Companies that mitigate climate change reduce their cost of capital
2024-07-08
Fukuoka, Japan —The climate crisis is hitting home with more frequent extreme weather events. Companies, particularly those in high-emission industries, are major contributors to global carbon emissions, therefore making them key players in the fight against climate change. Recognizing this responsibility, many businesses are now taking proactive measures to reduce their carbon footprint, by reducing carbon emissions and transparently sharing their environmental strategies and data. The Task Force on Climate-Related Financial Disclosures ...

Case Western Reserve University receives $1.5M grant from Foundation Fighting Blindness to test possible new treatment for inherited retinal disease

Case Western Reserve University receives $1.5M grant from Foundation Fighting Blindness to test possible new treatment for inherited retinal disease
2024-07-08
CLEVELAND—There’s only one U.S. Food and Drug Administration-approved therapy for an inherited retinal disease, and dozens of retinitis pigmentosa (RP) genes for which no therapy is available. With a new three-year, $1.5 million grant from the Foundation Fighting Blindness, Shigemi Matsuyama, an associate professor of ophthalmology and visual sciences at the Case Western Reserve University School of Medicine, will test a possible breakthrough drug that can be taken by mouth—one that may address many RP disease manifestations, regardless of the underlying genetic mutation. “We believe it can serve as the basis of an oral medicine to prevent blindness in RP ...

How to stop cancer cachexia? Start at the top

How to stop cancer cachexia? Start at the top
2024-07-08
Cancer is insidious. Throughout tumor progression, the disease hijacks otherwise healthy biological processes—like the body’s immune response—to grow and spread. When tumors elevate levels of an immune system molecule called Interleukin-6 (IL-6), it can cause severe brain dysfunction. In about 50%-80% of cancer patients, this leads to a lethal wasting disease called cachexia. “It’s a very severe syndrome,” says Cold Spring Harbor Laboratory (CSHL) Professor Bo Li.  “Most people with cancer die of cachexia instead of cancer. And once the patient enters this stage, there’s ...

Pulsed field ablation procedures found safe and effective for atrial fibrillation patients

Pulsed field ablation procedures found safe and effective for atrial fibrillation patients
2024-07-08
Pulsed field ablation (PFA) is safe for treating patients with common types of atrial fibrillation (AF), according to the largest study of its kind on this new technology, led by the Icahn School of Medicine at Mount Sinai.   The “MANIFEST-17K” international study is the first to show important safety outcomes in a large patient population, including no significant risk of esophageal damage, with PFA. PFA is the latest ablation modality approved by the Food and Drug Administration that can be used to restore a regular heartbeat. The findings, published July 8 in Nature Medicine, could lead to more frequent use of PFA instead of conventional therapies to manage AF patients. “MANIEFST-17K ...

Why some abusive bosses get a pass from their employees

2024-07-08
COLUMBUS, Ohio – Why do employees sometimes accept working for an abusive boss?   A new study suggests that when a leader is seen as a high performer, employees are more likely to label abuse as just “tough love.”   Results showed that workers were less likely to show hostility to abusive bosses when the leader’s performance was high, and employees were even likely to think their career could be boosted by a successful – if abusive – boss.   The findings suggest that employees may be reluctant to call a successful boss abusive – ...

LAST 30 PRESS RELEASES:

Link found between kneecap shape and debilitating joint disease

Generative AI tools like Pix2Pix–BicycleGAN are revolutionizing landscape design by enhancing masterplan generation and rendering

Expanding APAC presence, Insilico Medicine seals strategic collaboration on AI-driven mash therapy development with Korean Biotech Therasid Bioscience

When it comes to butterflies, people prefer pretty ones. That’s a problem for scientists.

UBC Okanagan study raises concerns about partner violence in queer relationships

Human-infecting parasite produces sterile soldiers like ants and termites

The unintended consequences of success against malaria

Taco-shaped arthropod from Royal Ontario Museum’s Burgess Shale fossils gives new insights into the history of the first mandibulates

Butterflies accumulate enough static electricity to attract pollen without contact, new research finds

Eyes for Love: Searching for light and a mate in the deep, dark sea, male dragonfishes grow larger eyes than the females they seek

PNNL scientists tap nation’s fastest computers to explore critical science questions

Peri-operative care of transgender and gender-diverse individuals: new guidance for clinicians and departments published

Clinical psychologist’s book addresses largely ignored problem: social anxiety

Researchers leveraging AI to train (robotic) dogs to respond to their masters

Drawing water from dry air

Combining trapped atoms and photonics for new quantum devices

A new way to make element 116 opens the door to heavier atoms

New genetic tool could identify drug targets for diseases associated with metabolic dysfunction

Plant Biologist Siobhan Brady named HHMI Investigator

Long-acting injectable cabotegravir for HIV prevention is safe in pregnancy

Large language models don’t behave like people, even though we may expect them to

NREL researchers highlight opportunities for manufacturing perovskite solar panels with a long-term vision

Top Medicare advantage plans less available in disadvantaged areas

Better carbon storage better carbon storage with stacked geology with stacked geology

Sharp temperature reduction for quantum dots in polymer by highly efficient heat dissipation pathways

UAF researcher creates way to detect elusive volcanic vibrations

Lissajous pattern multi-pass cell: Enhancing high sensitivity and simultaneous dual-gas LITES sensing

Asexual reproduction usually leads to a lack of genetic diversity. Not for these ants.

Mini lungs make major COVID-19 discoveries possible

Exploratory analysis associates HIV drug abacavir with elevated cardiovascular disease risk in large global trial

[Press-News.org] Study backs RSV vaccine safety during pregnancy